These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2886 related items for PubMed ID: 12670926

  • 21. The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis.
    Perkins CL, Fang G, Kim CN, Bhalla KN.
    Cancer Res; 2000 Mar 15; 60(6):1645-53. PubMed ID: 10749135
    [Abstract] [Full Text] [Related]

  • 22. Failure of Bcl-2 to block mitochondrial dysfunction during TRAIL-induced apoptosis. Tumor necrosis-related apoptosis-inducing ligand.
    Kim EJ, Suliman A, Lam A, Srivastava RK.
    Int J Oncol; 2001 Jan 15; 18(1):187-94. PubMed ID: 11115558
    [Abstract] [Full Text] [Related]

  • 23. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex.
    Izeradjene K, Douglas L, Delaney AB, Houghton JA.
    Cancer Res; 2004 Nov 01; 64(21):8036-44. PubMed ID: 15520213
    [Abstract] [Full Text] [Related]

  • 24. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A, Lam A, Datta R, Srivastava RK.
    Oncogene; 2001 Apr 19; 20(17):2122-33. PubMed ID: 11360196
    [Abstract] [Full Text] [Related]

  • 25. Effect of Bax deficiency on death receptor 5 and mitochondrial pathways during endoplasmic reticulum calcium pool depletion-induced apoptosis.
    He Q, Montalbano J, Corcoran C, Jin W, Huang Y, Sheikh MS.
    Oncogene; 2003 May 01; 22(17):2674-9. PubMed ID: 12730681
    [Abstract] [Full Text] [Related]

  • 26. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c.
    Korsmeyer SJ, Wei MC, Saito M, Weiler S, Oh KJ, Schlesinger PH.
    Cell Death Differ; 2000 Dec 01; 7(12):1166-73. PubMed ID: 11175253
    [Abstract] [Full Text] [Related]

  • 27. Differential involvement of Bax and Bak in TRAIL-mediated apoptosis of leukemic T cells.
    Han J, Goldstein LA, Gastman BR, Rabinovitz A, Wang GQ, Fang B, Rabinowich H.
    Leukemia; 2004 Oct 01; 18(10):1671-80. PubMed ID: 15356645
    [Abstract] [Full Text] [Related]

  • 28. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
    Zhang L, Fang B.
    Cancer Gene Ther; 2005 Mar 01; 12(3):228-37. PubMed ID: 15550937
    [Abstract] [Full Text] [Related]

  • 29. Stimulation of the mitogen-activated protein kinase pathway antagonizes TRAIL-induced apoptosis downstream of BID cleavage in human breast cancer MCF-7 cells.
    Sarker M, Ruiz-Ruiz C, Robledo G, López-Rivas A.
    Oncogene; 2002 Jun 20; 21(27):4323-7. PubMed ID: 12082620
    [Abstract] [Full Text] [Related]

  • 30. Defining characteristics of Types I and II apoptotic cells in response to TRAIL.
    Ozören N, El-Deiry WS.
    Neoplasia; 2002 Jun 20; 4(6):551-7. PubMed ID: 12407450
    [Abstract] [Full Text] [Related]

  • 31. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
    Hasenjäger A, Gillissen B, Müller A, Normand G, Hemmati PG, Schuler M, Dörken B, Daniel PT.
    Oncogene; 2004 Jun 03; 23(26):4523-35. PubMed ID: 15064710
    [Abstract] [Full Text] [Related]

  • 32. Hypoxia inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by blocking Bax translocation.
    Kim M, Park SY, Pai HS, Kim TH, Billiar TR, Seol DW.
    Cancer Res; 2004 Jun 15; 64(12):4078-81. PubMed ID: 15205314
    [Abstract] [Full Text] [Related]

  • 33. Cephalostatin 1 selectively triggers the release of Smac/DIABLO and subsequent apoptosis that is characterized by an increased density of the mitochondrial matrix.
    Dirsch VM, Müller IM, Eichhorst ST, Pettit GR, Kamano Y, Inoue M, Xu JP, Ichihara Y, Wanner G, Vollmar AM.
    Cancer Res; 2003 Dec 15; 63(24):8869-76. PubMed ID: 14695204
    [Abstract] [Full Text] [Related]

  • 34. Role of mitochondria in aspirin-induced apoptosis in human gastric epithelial cells.
    Redlak MJ, Power JJ, Miller TA.
    Am J Physiol Gastrointest Liver Physiol; 2005 Oct 15; 289(4):G731-8. PubMed ID: 15976387
    [Abstract] [Full Text] [Related]

  • 35. Real-time single cell analysis of Smac/DIABLO release during apoptosis.
    Rehm M, Düssmann H, Prehn JH.
    J Cell Biol; 2003 Sep 15; 162(6):1031-43. PubMed ID: 12975347
    [Abstract] [Full Text] [Related]

  • 36. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine.
    Boya P, Gonzalez-Polo RA, Poncet D, Andreau K, Vieira HL, Roumier T, Perfettini JL, Kroemer G.
    Oncogene; 2003 Jun 19; 22(25):3927-36. PubMed ID: 12813466
    [Abstract] [Full Text] [Related]

  • 37. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms.
    Shankar S, Singh TR, Srivastava RK.
    Prostate; 2004 Sep 15; 61(1):35-49. PubMed ID: 15287092
    [Abstract] [Full Text] [Related]

  • 38. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
    Walczak H, Bouchon A, Stahl H, Krammer PH.
    Cancer Res; 2000 Jun 01; 60(11):3051-7. PubMed ID: 10850456
    [Abstract] [Full Text] [Related]

  • 39. Overexpression of BAD potentiates sensitivity to tumor necrosis factor-related apoptosis-inducing ligand treatment in the prostatic carcinoma cell line LNCaP.
    Taghiyev AF, Guseva NV, Harada H, Knudson CM, Rokhlin OW, Cohen MB.
    Mol Cancer Res; 2003 May 01; 1(7):500-7. PubMed ID: 12754297
    [Abstract] [Full Text] [Related]

  • 40. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.
    Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 145.